Nrx Pharmaceuticals Inc Stock Ownership - Who owns Nrx Pharmaceuticals?

Insider buying vs selling

Have Nrx Pharmaceuticals Inc insiders been buying or selling?
Chaim HurvitzDirector2023-08-3070,000$0.29
Aaron GorovitzDirector2023-08-3035,000$0.32
Jonathan C. JavittChief Scientist2023-08-23100,000$0.33
Jonathan C. JavittChief Scientist2023-08-22200,000$0.32
Stephen H. WillardCHIEF EXECUTIVE OFFICER2022-12-1650,000$1.17
Voorhees Seth VanCHIEF FINANCIAL OFFICER2022-12-1630,000$1.10
Jonathan C. JavittDirector2022-12-07400,000$1.00
Daniel C. Javitt10% Owner2022-11-308,441$1.51
Daniel C. Javitt10% Owner2022-11-2913,730$1.50
Patrick John FlynnDirector2022-11-281,750$1.25

1 of 4

NRXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRXP insiders and whales buy or sell their stock.

NRXP Shareholders

What type of owners hold Nrx Pharmaceuticals Inc stock?
Jonathan C. Javitt35.78%29,236,658$7.48MInsider
Daniel C. Javitt28.89%23,606,657$6.04MInsider
Armistice Capital LLC6.90%5,636,000$1.44MInstitution
Chaim Hurvitz2.97%2,423,236$620.35kInsider
Brac Lending Group LLC2.73%2,228,435$570.48kInsider
Vanguard Group Inc1.81%1,478,153$378.41kInstitution
Polar Asset Management Partners Inc1.23%1,005,536$257.42kInsider
Sabby Management LLC0.86%699,731$179.13kInstitution
Big Rock Partners Sponsor LLC0.64%519,315$132.94kInsider
Cvi Holdings LLC0.59%483,569$123.79kInstitution

1 of 3

NRXP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRXP12.11%73.50%Net BuyingNet Buying
MAIA2.36%27.93%Net Buying
SEEL17.94%44.85%Net BuyingNet Buying

Nrx Pharmaceuticals Stock Ownership FAQ

Who owns Nrx Pharmaceuticals?

Nrx Pharmaceuticals (NASDAQ: NRXP) is owned by 12.11% institutional shareholders, 73.50% Nrx Pharmaceuticals insiders, and 14.39% retail investors. Jonathan C. Javitt is the largest individual Nrx Pharmaceuticals shareholder, owning 29.24M shares representing 35.78% of the company. Jonathan C. Javitt's Nrx Pharmaceuticals shares are currently valued at $7.48M.

If you're new to stock investing, here's how to buy Nrx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.